Program

Breast and Gynecologic Cancer Advances | Women’s Cancer Series

Join Stanford Medicine faculty for a discussion of updates in breast and gynecologic cancer management. Learn about techniques for managing triple-negative and hereditary breast cancer, the use of sentinel node biopsy in staging breast cancer, progress toward a cure for ovarian cancer, and hyperthermic intraperitoneal chemotherapy (HIPEC) for metastatic gynecologic cancers. Come away with a deeper understanding of advances in diagnosis and treatment to help your patients achieve their best outcomes.

A recording of this virtual event is available. The program is not available for CME credit.

Learning Objectives

At the conclusion of this activity, learners should be able to:

  • Identify candidates for sentinel node biopsies
  • Understand treatment strategies for ovarian cancer, from diagnosis through potential recurrence
  • Understand heated intraperitoneal chemotherapy (HIPEC) in treating metastatic gynecologic cancers
  • Identify treatment strategies for triple-negative and hereditary breast cancer

Speakers

Melinda L. Telli, MD
Medical Oncologist, Stanford Health Care
Associate Professor – Medicine, Stanford University School of Medicine
Director, Breast Cancer Program, Stanford Cancer Institute

Oliver Dorigo, MD, PhD
Gynecologic Oncologist, Stanford Health Care
Associate Professor – Obstetrics & Gynecology, Stanford University School of Medicine
Director, Gynecologic Cancer Program, Stanford Cancer Institute

Kimberly Sue Stone, MD
Breast Surgeon, Stanford Health Care
Clinical Assistant Professor – Surgery, Stanford University School of Medicine
Director, Stanford Medicine Network Breast Oncology Program

Amer Karam, MD
Gynecologic Oncologist, Stanford Health Care
Clinical Professor – Obstetrics & Gynecology, Stanford University School of Medicine

Specialty Areas of Interest

  • Oncology
  • Breast Pathology
  • Gynecologic Pathology

Women's Cancer Center Highlights

The Stanford Women’s Cancer Center offers advanced treatments for breast and gynecologic cancers, combining medical innovation with a commitment to supportive, attentive care. Within the Women’s Cancer Center, the Breast Cancer Program and the Gynecologic Cancer Program offer specialized expertise in treating every stage and subtype of breast and gynecologic cancer. We offer team-based treatment planning that brings together medical, surgical, and radiation oncologists, as well as dedicated breast radiologists, pathologists, cancer geneticists, nurses, social workers, and psychologists. The Stanford Medicine Cancer Center is part of the Stanford Cancer Institute, an NCI-Designated Comprehensive Cancer Center.

Event Details

Webinar

 

Monday, October 18, 2021
5:00 p.m. - 6:00 p.m.

A recording of this virtual event is available. The program is not available for CME credit.